- 1) Laube, B. L., Benedict, G. W., and Dobs, A. S., The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes. Chest, 114, 1734–1739 (1998).
- 2) Patton, J. S., Bukar, J., and Nagarajan, S., Inhaled insulin. Adv. Drug Deliv. Rev., 35, 235–247 (1999).
- 3) Pillai, O., and Panchagnula, R., Insulin therapies: past, present and future. Drug Discov. Today, 6, 1056–1061 (2001).
- 4) Liu, F. Y., Shao, Z., Kildsig, D. O., and Mitra, A. K., Pulmonary delivery of free and liposomal insulin. Pharm. Res., 10, 228–232 (1993).
- 5) Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., and Langer, R., Large porous particles for pulmonary drug delivery. Science, 276, 1868–1871 (1997).
- 6) Kwon, J. H., and Kim, C. W., Korea Patent 0327597 (Feb. 23, 2002).
- 7) Kwon, J. H., and Kim, C. W., A novel insulin microcrystal preparation using a seed zone method. J. Crystal Growth, 263, 536–543 (2004).
- 8) Kwon, J. H., Lee, B. H., Lee, J. J., and Kim, C. W., Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery. Eur. J. Pharm. Sci., 22, 107–116 (2004).
- 9) Choi, S. H., Kwon, J. H., and Kim, C. W., Microencapsulation of insulin microcrystals. Biosci. Biotechnol. Biochem., 68, 749–752 (2004).
- 10) Hirai, S., Yashiki, T., and Mima, H., Effect of surfactants on the nasal absorption of insulin in rats. Int. J. Pharm., 9, 165–172 (1981).
- 11) Felig, P., Landmark perspective: protamine insulin: Hagedorn’s pioneering contribution to drug delivery in the management of diabetes. J. Am. Med. Assoc., 251, 393–396 (1984).
- 12) Ilouz, R., Kaidanovich, O., Gurwitz, D., and Eldar-Finkelman, H., Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem. Biophys. Res. Commun., 295, 102–106 (2002).
- 13) Kojima, Y., Yoshikawa, Y., Ueda, E., Ueda, R., Yamamoto, S., Kumekawa, K., Yanagihara, N., and Sakurai, H., Insulinomimetic zinc(II) complexes with natural production: in vitro evaluation and blood glucose lowering effect in KK-Ay mice with type 2 diabetes mellitus. Chem. Pharm. Bull., 51, 1006–1008 (2003).
- 14) Brange, J., Havelund, S., Hommel, E., Sorensen, E., and Kuhl, C., Neutral insulin solutions physically stabilized by addition of Zn2+. Diabet. Med., 3, 532–536 (1986).
- 15) Schlichtkrull, J., Insulin crystals: chemical and biological studies on insulin crystals and insulin zinc suspensions. Acta Chem. Scand., 10, 1459 (1961).
Bioscience, Biotechnology, and Biochemistry
Volume 70, 2006 - Issue 4